NCT05415969

Uremic Pruritus Among Adults on Dialysis in the French Speaking Part of Switzerland

Extracted Fields (from Registry)
Protocol IDNCT05415969
Registration Date2022-06-13
Statuscompleted
SponsorUniversity of Applied Sciences of Western Switzerland
CountrySwitzerland
Industrynot industry
Blindingunblinded
Center Typesingel-center RCT
Scopenational RCT
First Patient In2022-09-01
Last Patient Out2023-10-09
Publicationn
Gender %ALL
Mean Age18 Years -
LLM Classifications (Side-by-Side)
Field GLM
glm-5.1
8601ms / 9266 tok
CLAUDE
claude-sonnet-4-20250514
Thinking: claude-opus-4-20250514
4867ms / 10626 tok
OPENAI
gpt-4o
Thinking: o3
3029ms / 9083 tok
Review
rct_type N/A N/A N/A OK
cancer_status non-cancer non-cancer non-cancer OK
non_cancer_spec renal renal renal OK
setting_patient outpatient outpatient outpatient OK
setting_place other other other OK
feasibility N/A N/A N/A OK
intervention_pharmacologic no no no OK
intervention_chemo_immuno_radio no no no OK
intervention_complementary no no no OK
intervention_device no no no OK
intervention_psychological no no no OK
intervention_complex no no no OK
intervention_acp no no no OK
intervention_music no no no OK
intervention_screening no no no OK
intervention_palliative no no no OK
intervention_education no no
shaky reasoning
✓ Unanimous Initial: no
no no → no
shaky reasoning
✓ Unanimous Initial: no Requery: no — This is an observational study focused on identifying prevalence and severity of chronic kidney disease-associated pruritus through measurements and assessments, not providing educational interventions to participants.
no yes → no
shaky reasoning
✓ Unanimous Initial: yes Requery: no — The trial's primary focus is on identifying the prevalence and severity of CKD-aP among dialysis patients, not on providing education as a principal intervention.
OK
intervention_digital no no no OK
intervention_other no no → yes
shaky reasoning
✗ No consensus Initial: no Requery: yes — The trial is an observational study focused on identifying the prevalence and severity of a condition and measuring biomarkers, which fits the residual category as it does not involve pharmacologic, device, or other specified active interventions.
no no → no → yes
shaky reasoning
✗ No consensus Initial: no Requery: no — This is an observational study focused on identifying prevalence and severity of CKD-associated pruritus through questionnaires and biomarker measurements, which does not constitute an active intervention but rather assessment/screening activities. Thinking: yes — This is an observational assessment study measuring prevalence and biomarkers, not fitting any specified intervention categories.
yes yes → no → no
shaky reasoning
✗ No consensus Initial: yes Requery: no — The study is observational and focuses on assessing the prevalence and severity of CKD-aP, which does not involve any intervention fitting exercise, nutritional, or environmental categories. Thinking: no — The study’s only intervention is assessing/screening patients to identify prevalence and severity of pruritus, which fits the screening category.
outcome_symptom yes yes yes OK
outcome_qol no no no OK
outcome_dignity no no no OK
outcome_cost no no no OK
outcome_other yes yes → yes
shaky reasoning
✗ No consensus Initial: yes Requery: yes — The secondary outcomes measure biomarkers (sweat electrolytes and urea) to investigate pathogenesis, which are not covered by symptom, QoL, dignity, or cost categories.
yes yes → no → no
shaky reasoning
✗ No consensus Initial: yes Requery: no — All outcomes measure symptom severity (pruritus) and associated biomarkers, which fall under the symptom category. Thinking: no — All outcomes measure symptom prevalence/severity (pruritus) or related biomarkers, with no caregiver, communication, survival, or other specified outcomes.
no no → no → yes
shaky reasoning
✗ No consensus Initial: no Requery: no — All outcomes focus on symptoms, specifically the prevalence and severity of pruritus, and do not extend to non-symptom categories. Thinking: yes — The trial measures laboratory biomarker outcomes (sweat electrolyte levels) that fall outside symptom, QoL, dignity, or cost domains.
pharmacologic_sub N/A N/A N/A OK
Back to Studies